(Q37763371)

22 August 2017

1 reference

title

Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use. (English)

1 reference

22 August 2017

0 references

Marina Y Zakharova

1

1 reference

22 August 2017

Rachel M Meyer

2

1 reference

22 August 2017

Kyle R Brandy

3

1 reference

22 August 2017

Yvonne H Datta

4

1 reference

22 August 2017

Marilyn S Joseph

5

1 reference

22 August 2017

Pamela J Schreiner

6

1 reference

22 August 2017

Gundu H Rao

7

1 reference

22 August 2017

Afshin A Divani

8

1 reference

22 August 2017

publication date

7 June 2010

1 reference

Clinical and Applied Thrombosis-Hemostasis

22 August 2017

published in

1 reference

22 August 2017

volume

17

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

323-331

1 reference

Contraception in the prepill era.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Condom knowledge, history of use, and attitudes among chemically addicted populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

The history of steroidal contraceptive development: the estrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Gregory Pincus and steroidal contraception: A new departure in the history of mankind

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Contraception for women: an evidence based overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

21 January 2018

Contraceptive implants

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Effect of oral contraceptives and ovarian cycle on platelet function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Mechanisms of thrombosis related to hormone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Female hormones and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Oral contraceptives, thrombosis and haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Effects of oral contraceptives on hemostasis and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Mutation in blood coagulation factor V associated with resistance to activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Resistance to activated protein C in healthy women taking oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Factor VII activation and oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Oral contraceptive use alters the balance of platelet prostaglandin and thromboxane synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Alterations in platelet function during the ovarian cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Effects of age, sex and the oral contraceptive on the platelet membrane fibrinogen binding site (glycoprotein IIb/IIIa)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Oral contraceptive use and association with glucose, insulin, and diabetes in young adult women: the CARDIA Study. Coronary Artery Risk Development in Young Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Transforming growth factor-beta1 inhibition of vascular smooth muscle cell activation is mediated via Smad3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Body weight and oral contraceptives are the most important modulators of serum CRP levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

The leucocyte count: correlates and relationship to coronary risk factors: the CARDIA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Combined oral contraceptive use among women with hypertension: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Oral contraceptives and myocardial infarction: results of the MICA case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Benefits and risks of third-generation oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Myocardial infarction and use of low-dose oral contraceptives: a pooled analysis of 2 US studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Combined oral contraceptives, smoking, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Oral contraceptives and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

Epidemiology of hormone-related venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029610368670

21 January 2018

Identifiers

DOI

10.1177/1076029610368670

1 reference

22 August 2017

1 reference